These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

235 related articles for article (PubMed ID: 30914360)

  • 1. Synthesis and evaluation of mono- and multi-hydroxyl low toxicity pH-sensitive cationic lipids for drug delivery.
    Zhao Z; Yao W; Wang N; Liu C; Zhou H; Chen H; Qiao W
    Eur J Pharm Sci; 2019 May; 133():69-78. PubMed ID: 30914360
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Poly(ethyleneglycol)-b-poly(ε-caprolactone-co-γ-hydroxyl-ε- caprolactone) bearing pendant hydroxyl groups as nanocarriers for doxorubicin delivery.
    Chang L; Deng L; Wang W; Lv Z; Hu F; Dong A; Zhang J
    Biomacromolecules; 2012 Oct; 13(10):3301-10. PubMed ID: 22931197
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Galactose-Containing Polymer-DOX Conjugates for Targeting Drug Delivery.
    Sun Y; Zhang J; Han J; Tian B; Shi Y; Ding Y; Wang L; Han J
    AAPS PharmSciTech; 2017 Apr; 18(3):749-758. PubMed ID: 27287244
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Vessel-Targeted Chemophototherapy with Cationic Porphyrin-Phospholipid Liposomes.
    Luo D; Geng J; Li N; Carter KA; Shao S; Atilla-Gokcumen GE; Lovell JF
    Mol Cancer Ther; 2017 Nov; 16(11):2452-2461. PubMed ID: 28729400
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A comprehensive mathematical model of drug release kinetics from nano-liposomes, derived from optimization studies of cationic PEGylated liposomal doxorubicin formulations for drug-gene delivery.
    Haghiralsadat F; Amoabediny G; Helder MN; Naderinezhad S; Sheikhha MH; Forouzanfar T; Zandieh-Doulabi B
    Artif Cells Nanomed Biotechnol; 2018 Feb; 46(1):169-177. PubMed ID: 28376641
    [TBL] [Abstract][Full Text] [Related]  

  • 6. PEGylated Dendrimer-Doxorubicin Cojugates as pH-Sensitive Drug Delivery Systems: Synthesis and In Vitro Characterization.
    She W; Pan D; Luo K; He B; Cheng G; Zhang C; Gu Z
    J Biomed Nanotechnol; 2015 Jun; 11(6):964-78. PubMed ID: 26353586
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Surface functionalization of doxorubicin-loaded liposomes with octa-arginine for enhanced anticancer activity.
    Biswas S; Dodwadkar NS; Deshpande PP; Parab S; Torchilin VP
    Eur J Pharm Biopharm; 2013 Aug; 84(3):517-25. PubMed ID: 23333899
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Vascular targeting of doxorubicin using cationic liposomes.
    Wu J; Lee A; Lu Y; Lee RJ
    Int J Pharm; 2007 Jun; 337(1-2):329-35. PubMed ID: 17275230
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Selenium-functionalized liposomes for systemic delivery of doxorubicin with enhanced pharmacokinetics and anticancer effect.
    Xie Q; Deng W; Yuan X; Wang H; Ma Z; Wu B; Zhang X
    Eur J Pharm Biopharm; 2018 Jan; 122():87-95. PubMed ID: 29032193
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Development and characterization of a novel cationic PEGylated niosome-encapsulated forms of doxorubicin, quercetin and siRNA for the treatment of cancer by using combination therapy.
    Hemati M; Haghiralsadat F; Yazdian F; Jafari F; Moradi A; Malekpour-Dehkordi Z
    Artif Cells Nanomed Biotechnol; 2019 Dec; 47(1):1295-1311. PubMed ID: 30033768
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Amphiphilic Diblock Terpolymer PMAgala-b-P(MAA-co-MAChol)s with Attached Galactose and Cholesterol Grafts and Their Intracellular pH-Responsive Doxorubicin Delivery.
    Wang Z; Luo T; Sheng R; Li H; Sun J; Cao A
    Biomacromolecules; 2016 Jan; 17(1):98-110. PubMed ID: 26682643
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Reductively degradable α-amino acid-based poly(ester amide)-graft-galactose copolymers: facile synthesis, self-assembly, and hepatoma-targeting doxorubicin delivery.
    Lv J; Sun H; Zou Y; Meng F; Dias AA; Hendriks M; Feijen J; Zhong Z
    Biomater Sci; 2015 Jul; 3(7):1134-46. PubMed ID: 26221946
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Doxorubicin-loaded nanocarriers: A comparative study of liposome and nanostructured lipid carrier as alternatives for cancer therapy.
    Fernandes RS; Silva JO; Monteiro LOF; Leite EA; Cassali GD; Rubello D; Cardoso VN; Ferreira LAM; Oliveira MC; de Barros ALB
    Biomed Pharmacother; 2016 Dec; 84():252-257. PubMed ID: 27664949
    [TBL] [Abstract][Full Text] [Related]  

  • 14. pH-sensitive micelles self-assembled from multi-arm star triblock co-polymers poly(ε-caprolactone)-b-poly(2-(diethylamino)ethyl methacrylate)-b-poly(poly(ethylene glycol) methyl ether methacrylate) for controlled anticancer drug delivery.
    Yang YQ; Zhao B; Li ZD; Lin WJ; Zhang CY; Guo XD; Wang JF; Zhang LJ
    Acta Biomater; 2013 Aug; 9(8):7679-90. PubMed ID: 23669619
    [TBL] [Abstract][Full Text] [Related]  

  • 15. 2,2'-Dithiodisuccinic acid-stabilized polyion complex micelles for pH and reduction dual-responsive drug delivery.
    Du Y; Yan W; Lian H; Xiang C; Duan L; Xiao C
    J Colloid Interface Sci; 2018 Jul; 522():74-81. PubMed ID: 29579564
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Designed Synthesis of Lipid-Coated Polyacrylic Acid/Calcium Phosphate Nanoparticles as Dual pH-Responsive Drug-Delivery Vehicles for Cancer Chemotherapy.
    Wang X; Zhang M; Zhang L; Li L; Li S; Wang C; Su Z; Yuan Y; Pan W
    Chemistry; 2017 May; 23(27):6586-6595. PubMed ID: 28218434
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Chitooligosaccharides Modified Reduction-Sensitive Liposomes: Enhanced Cytoplasmic Drug Delivery and Osteosarcomas-Tumor Inhibition in Animal Models.
    Yin X; Chi Y; Guo C; Feng S; Liu J; Sun K; Wu Z
    Pharm Res; 2017 Oct; 34(10):2172-2184. PubMed ID: 28726003
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Design and evaluation of pH-sensitive liposomes constructed by poly(2-ethyl-2-oxazoline)-cholesterol hemisuccinate for doxorubicin delivery.
    Xu H; Hu M; Yu X; Li Y; Fu Y; Zhou X; Zhang D; Li J
    Eur J Pharm Biopharm; 2015 Apr; 91():66-74. PubMed ID: 25660909
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Enhanced siRNA delivery using cationic liposomes with new polyarginine-conjugated PEG-lipid.
    Kim HK; Davaa E; Myung CS; Park JS
    Int J Pharm; 2010 Jun; 392(1-2):141-7. PubMed ID: 20347025
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Tat peptide and hexadecylphosphocholine introduction into pegylated liposomal doxorubicin: An in vitro and in vivo study on drug cellular delivery, release, biodistribution and antitumor activity.
    Teymouri M; Badiee A; Golmohammadzadeh S; Sadri K; Akhtari J; Mellat M; Nikpoor AR; Jaafari MR
    Int J Pharm; 2016 Sep; 511(1):236-244. PubMed ID: 27363937
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.